Human immunodeficiency virus patients with low CD4 counts are more likely to have precancerous polyps identified during index colonoscopy

Table 3 Logistic regression of HIV control and precancerous polyps controlling for other variables

Variable	Odds ratio (95%CI)	P value
CD4 < 500 vs CD4 > 500	9.01 (1.69-47.97)	0.0100
Female vs male	2.58 (0.64-10.34)	0.1839
BMI	0.99 (0.89-1.11)	0.8956
NRTIs	1.50 (0.27-8.36)	0.6425
NNRTIs	10.23 (1.08-97.15)	0.0428
PIs	3.23 (0.35-29.98)	0.3032
FIs	0.44 (0.01-23.08)	0.6832
INSTIs	4.01 (0.23-69.67)	0.3403
CCR5 antagonists	15.39 (0.22-999.99)	0.2073

BMI: Body mass index; CI: Confidence interval; CCR5: C-C chemokine receptor 5; FIs: Fusion inhibitors; INSTI: Integrase strand transfer inhibitors; NNRTIs: Non-nucleoside reverse transcriptase inhibitors; NRTIs: Nucleoside reverse transcriptase inhibitors; PIs: Protease inhibitors.